Jimmy Andrew Rotolo
13Patents
2h-index
9Co-inventors
43Inventor score
Filing activity: May 6, 2008 → Dec 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9499594B2 | Biofilm prevention, disruption and treatment with bacteriophage lysin | Emerging Cross-Sectional Technologies | 5 | Active |
| US8562993B2 | Methods for treating GI syndrome and graft versus host disease | Human Necessities | 3 | Active |
| US10316077B2 | Cell-penetrating ATF5 polypeptides and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10450385B2 | Anti-ceramide antibodies | Chemistry; Metallurgy | 1 | Active |
| US10525100B2 | ATF5 peptide variants and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12121525B2 | Methods for treating GI syndrome and graft versus host disease | Human Necessities | 0 | Active |
| US9592238B2 | Anti-ceramide monoclonal antibody 2A2 | Human Necessities | 0 | Active |
| US11878047B2 | ATF5 peptide variants and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11524046B2 | Biofilm prevention, disruption and treatment with bacteriophage lysin | Emerging Cross-Sectional Technologies | 0 | Active |
| US11447572B2 | Anti-ceramide antibodies | Chemistry; Metallurgy | 0 | Active |
| US12208131B2 | ATF5 peptide variants and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10722577B2 | Methods for treating GI syndrome and graft versus host disease | Chemistry; Metallurgy | 0 | Active |
| US11207329B2 | Methods for treating GI syndrome and graft versus host disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.